Dolby Laboratories insider sale: 6,164 shares at $66.12 reported

Rhea-AI Filing Summary

Dolby Laboratories (DLB) senior vice president of entertainment reported a sale of Class A common stock. On 11/20/2025, the executive sold 6,164 shares of Dolby Class A common stock at a price of $66.12 per share. After this transaction, the executive beneficially owns 115,338 shares of Class A common stock. This total includes 48,526 shares underlying restricted stock units that may be forfeited if they do not vest, as well as 284 shares and 67 shares acquired through the company’s Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025.

Insider Trade Summary

Net Seller: 6,164 shares ($407,564)

Net Sell 1 txn

Insider Couling John D

Role SVP, Entertainment

Sold 6,164 shs ($408K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	6,164	$66.12	$408K

Holdings After Transaction: Class A Common Stock — 115,338 shares (Direct)

Footnotes (1)

1. Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Couling John D

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Entertainment

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/20/2025		S		6,164	D	$66.12	115,338(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

2. Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively.

	/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dolby Laboratories (DLB) report in this Form 4?

The filing reports that a Dolby Laboratories senior vice president sold 6,164 shares of Class A common stock on 11/20/2025 at $66.12 per share.

How many Dolby (DLB) shares does the executive own after the reported sale?

Following the reported transaction, the executive beneficially owns 115,338 shares of Dolby Class A common stock.

How many Dolby (DLB) restricted stock units does the executive hold?

The beneficial ownership figure includes 48,526 shares of Class A common stock underlying restricted stock units that are subject to forfeiture until they vest.

Are Employee Stock Purchase Plan shares included in the Dolby (DLB) ownership total?

Yes. The total includes 284 shares and 67 shares acquired under Dolby’s Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively.

What is the role of the reporting person at Dolby Laboratories (DLB)?

The reporting person serves as SVP, Entertainment at Dolby Laboratories.

Is this Dolby (DLB) Form 4 filed by one or multiple reporting persons?

This Form 4 is indicated as being filed by one reporting person, not a group filing.